newsfilter
← Latest News
GlobeNewswire·

Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference

MALVERN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri,